当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析

皓元医药

(688131)

  

流通市值:76.89亿  总市值:78.68亿
流通股本:2.06亿   总股本:2.11亿

皓元医药(688131)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.41亿元,每股收益0.68元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益272172.04万元,未分配利润76868.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产468350.26万元,负债196178.22万元。

利润表
报告期2024-09-302024-06-302024-03-312023-12-31
营业总收入1,619,063,344.91,055,549,087.12504,874,103.591,880,046,769.14
营业总成本1,383,328,088.18919,361,955.83465,236,626.831,672,706,963.81
营业利润157,760,861.7278,476,846.7816,593,800.36128,328,584.25
利润总额157,832,706.4378,640,841.816,700,129.51128,192,543.96
净利润140,779,655.4168,918,893.516,536,169.84126,307,603.99
其他综合收益14,035,099.2912,837,511.63347,032.14827,004.88
综合收益总额154,814,754.781,756,405.1316,883,201.98127,134,608.87
资产负债表
报告期2024-09-302024-06-302024-03-312023-12-31
流动资产合计2,376,880,587.72,227,859,454.342,242,692,568.832,188,265,705.87
非流动资产合计2,306,622,057.72,144,790,659.772,078,750,166.162,003,942,224.38
资产总计4,683,502,645.44,372,650,114.114,321,442,734.994,192,207,930.25
流动负债合计1,210,004,419.41,136,910,737.461,211,266,462.661,163,812,417.73
非流动负债合计751,777,802.32592,842,163.17546,855,693.07502,117,458.82
负债合计1,961,782,221.721,729,752,900.631,758,122,155.731,665,929,876.55
归属于母公司股东权益合计2,704,179,683.132,621,241,196.552,543,858,967.162,509,078,803.36
股东权益合计2,721,720,423.682,642,897,213.482,563,320,579.262,526,278,053.7
负债和股东权益合计4,683,502,645.44,372,650,114.114,321,442,734.994,192,207,930.25
现金流量表
报告期2024-09-302024-06-302024-03-312023-12-31
经营活动现金流入小计1,654,346,586.741,057,675,016.59474,799,584.52,018,632,068.17
经营活动现金流出小计1,495,338,546.22980,575,236.32446,474,098.492,082,238,246.64
经营活动产生的现金流量净额159,008,040.5277,099,780.2728,325,486.01-63,606,178.47
投资活动现金流入小计19,913,172.0416,778,889.08949,772.2929,549,566.38
投资活动现金流出小计199,118,409.29193,442,522.91120,462,037.341,258,060,525.49
投资活动产生的现金流量净额-179,205,237.25-176,663,633.83-119,512,265.14-328,510,959.11
筹资活动现金流入小计605,040,019.79381,165,513.53165,645,972.06815,321,980.1
筹资活动现金流出小计568,561,561.84334,143,756.9105,667,376.89406,113,351.25
筹资活动产生的现金流量净额36,478,457.9547,021,756.6359,978,595.17409,208,628.85
汇率变动对现金及现金等价物的影响4,215,590.655,893,201.64-425,949.693,110,971.27
现金及现金等价物净增加额20,496,851.87-46,648,895.29-31,634,133.6520,202,462.54
期末现金及现金等价物余额495,962,815.48428,817,068.32443,831,829.96475,465,963.61
最新报告期:2024-11-15
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
国盛证券张金洋,胡偌碧0.901.201.682024-11-15
中信证券陈竹0.921.261.762024-11-07
开源证券余汝意0.931.301.682024-11-03
广发证券方程嫣,罗佳荣0.761.011.492024-09-10
中泰证券崔少煜,祝嘉琦0.771.051.412024-09-08
TOP↑